Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News
Open Access

Unpacking “long COVID”

Terry Murray
CMAJ March 01, 2021 193 (9) E318-E319; DOI: https://doi.org/10.1503/cmaj.1095923
Terry Murray
Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Experts at a recent World Health Organization meeting warned that the long-term complications of COVID-19, known as “long COVID” or post-COVID-19 condition, may become a crisis within a crisis for health systems already stretched thin by the pandemic.

If 10%–20% of people with COVID-19 experience long-term symptoms, as a growing body of evidence suggests, “we’ve got 10–20 million cases out there to manage,” said Dr. Daniel Altmann, a professor of immunology at Imperial College London.

According to Dr. Gail Carson, a researcher at the University of Oxford, “long COVID could become a pandemic of the pandemic.”

The meeting was the first in a series aimed at developing a global consensus on the case definition, diagnosis, and prevention and management of post COVID-19 condition. But according to Dr. Margaret Herridge, a professor of medicine at the University of Toronto who chaired the case definition working group, the four-hour meeting wasn’t enough time to make much progress on those points.

“You need to put all of these people in a room for a week and you’d have a fighting chance of getting somewhere,” she told CMAJ, noting that the WHO meeting was just a first step.

Part of the challenge will be working with incomplete evidence. Despite increasing recognition of the long-term complications of COVID-19, WHO director general Tedros Ghebreyesus said there still isn’t enough research on post-COVID-19 condition. He also urged countries to put a greater emphasis on rehabilitation in their pandemic response. “Long COVID should not fall through the cracks,” he said.

Several researchers also noted that research on long COVID has so far excluded children and pregnant women.

Figure

Experts met recently to define the long-term consequences of COVID-19, but a global consensus may take time to pin down.

Image copyright iStock.com/FG Trade. No standalone file use permitted.

Dr. John Marshall, a professor of surgery at the University of Toronto who chaired the diagnostics working group, said he hopes to collaborate with others who presented data at the meeting to pool information on their cohorts with long-term complications.

“That way, we could come up with a much more reproducible description of what the syndrome looks like and explore how it differs between, say, Brazil and China and the United Kingdom,” Marshall said. Pooling data “is going to be necessary before coming to any sensible conclusions about diagnosis, treatment or even an adequate description.”

The complexity of long COVID poses another challenge. One survey of more than 3700 patients with illness lasting more than a month turned up 205 symptoms affecting 10 organ systems, including neurocognitive, mental health, cardiac and pulmonary symptom clusters. Most patients had not returned to previous levels of work after six months, at which point the most common symptoms were fatigue, post-exertional malaise and cognitive dysfunction.

According to Marshall, these most common symptoms seemed to “disproportionately affect people who didn’t have severe COVID-19, but had milder cases and might not have been managed in a hospital setting,” and so there may be little documentation of their illness.

On the other hand, in patients who had severe disease, it can be difficult to distinguish the long-term effects of COVID-19 from those related to intensive care interventions. “Those of us who do post-ICU outcomes work know that these folks have lots of problems, but now we’ve got a whole world of them,” said Herridge.

However, it’s not the first time a pandemic has been linked to debilitating, long-term sequelae. The literature is replete with reports of similar long-term effects following the “Russian” flu pandemic of 1889–90, the “Spanish” flu pandemic of 1918–19, and the H1N1 pandemic in 2009, as well as outbreaks of chikungunya and Zika virus.

In the Lancet, Mark Honigsbaum and Lakshmi Krishnan noted that historical accounts of past pandemics “remind us of the limitations of narrow biomedical models and the importance of listening to patients’ narratives of illness.”

Getting a better handle on the manifestations of long COVID is important not just for clinical care and public health — it’s also going to be important for health resource planning.

According to Altmann, “we don’t know if this is a condition that lasts for months, years or is lifelong,” which could have “massive ramifications” on patients and health systems.

He estimates the number of people potentially affected by long COVID in the U.K. “is roughly equivalent to the number of rheumatoid arthritis patients,” who account for a substantial percentage of the National Health Service budget. “That’s an awful lot of hospital clinics, doctors, nurses and training that we really haven’t factored in.”

Footnotes

  • Posted on cmajnews.com on February 11, 2021

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 193 (9)
CMAJ
Vol. 193, Issue 9
1 Mar 2021
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Unpacking “long COVID”
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Unpacking “long COVID”
Terry Murray
CMAJ Mar 2021, 193 (9) E318-E319; DOI: 10.1503/cmaj.1095923

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Unpacking “long COVID”
Terry Murray
CMAJ Mar 2021, 193 (9) E318-E319; DOI: 10.1503/cmaj.1095923
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Saying goodbye to CMAJ News
  • National survey highlights worsening primary care access
  • How Canadian hospitals are decreasing carbon emissions
Show more News

Similar Articles

Collections

  • Topics
    • Global health
    • Infectious diseases
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire